The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
暂无分享,去创建一个
Hussein H. Aly | K. Chayama | M. Muramatsu | K. Shimotohno | T. Nozaki | M. Sugiyama | T. Wakita | C. Sureau | I. Shoji | M. Tsuge | Takanobu Kato | Kento Fukano | N. Watanabe | Yingfang Li | M. Oshima | Asako Murayama | Sameh A. Gad | K. Wakae